Strep throat overview: Difference between revisions

Jump to navigation Jump to search
Line 23: Line 23:
GAS is a gram-positive coccus (grows in chains), non-motile, non-spore forming, 0.5-1.2µm in size, catalase-negative, facultative anaerobes or obligate (strict) anaerobes, is capsulated (hyaluronic acid capsule) and requires enriched media (blood agar) to grow.
GAS is a gram-positive coccus (grows in chains), non-motile, non-spore forming, 0.5-1.2µm in size, catalase-negative, facultative anaerobes or obligate (strict) anaerobes, is capsulated (hyaluronic acid capsule) and requires enriched media (blood agar) to grow.


==Differentiating typhoid fever from other disease==
==Differentiating typhoid fever from other disease==  
Strep throat must be differentiated from other diseases that cause sore throat and fever such as [[epiglottitis]][[peritonsillar abscess]][[retropharyngeal abscess]], [[coxsackie virus]], [[herpangina]], [[influenza]], [[EBV]], [[adenovirus]], [[HIV]], [[measles]], [[rubella]], [[herpes simplex virus]], [[parainfluenza viruses]], [[coronaviruses]], [[rhinoviruses]], [[respiratory syncytial virus]] [[gonorrhea]], [[diphtheria]], [[tularemia]] [[mycoplasma pneumoniae]] and other causes such as foreign body (eg, fish bone), chemical exposure, and [[GERD]].
 
==Epidemiology and Demographics==
==Epidemiology and Demographics==
==Risk factors==
==Risk factors==

Revision as of 16:54, 21 October 2016

Strep throat Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes of Strep throat

Differentiating Strep throat from other Diseases

Epidemiology & Demographics

Risk Factors

Screening

Natural History, Complications & Prognosis

Diagnosis

History & Symptoms

Physical Examination

Lab Tests

X Ray

Echocardiography

Other Diagnostic Studies

Treatment

Medical Therapy

Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Strep throat overview On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Strep throat overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Strep throat overview

CDC on Strep throat overview

Strep throat overview in the news

Blogs on Strep throat overview

Directions to Hospitals Treating Strep throat

Risk calculators and risk factors for Strep throat overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Aysha Anwar, M.B.B.S[2]

Overview

Strep throat (or "Streptococcal pharyngitis", or "Streptococcal Sore Throat") is a form of Group A streptococcal infection that affects the pharynx.

Historical perspective

In the 4th century BC, Hippocrates described scarlet fever epidemic cause as S.pyogenes(GAS). In 1874, Billroth described streptococcal infection for the first time. In 1879, Louis Pasteur isolated the bacteria from a pregnant woman’s blood who was septic.n that had contracted Perpueral Fever. In the late 19th century, Rosenbach designated it as S.pyogenes. Blood agar patterns of streptococcal hemolysis was described by the Brown in 1919. Rebecca Lancefield identified distinct serogroups of beta-hemolytic streptococci in the 1930s.[1][2]

Pathophysiology

Group A strep pharyngitis is most commonly spread through direct person-to-person transmission, typically through saliva or nasal secretions from an infected person. Rarely, contaminated food, especially milk and milk products, can result in outbreaks.[3] The incubation period of group A strep pharyngitis is approximately 2 to 5 days.[3] Pathogenesis of GAS throat involves adhesion of bacteria to pharyngeal mucosa with the help of adhesins on the surface of organism. It then invades the mucosal tissue by producing various proteases and cytolysins causing inflammation manifesting as signs and symptoms of pharyngitis.[4] M protein on the surface of group A streptococcal infection plays important role in the pathogenesis of rheumatic fever.[5]

Causes

Strep throat is caused by B hemolytic Group A streptococcal infection. Human skin and mucous membrane are the only known reservoir.More than 80 serotypes identified based on M protien. GAS strep throat may be associated with serotypes such as M types 1, 3, 5, 6, 14, 18, 19, and 24.[4][6][7] GAS is a gram-positive coccus (grows in chains), non-motile, non-spore forming, 0.5-1.2µm in size, catalase-negative, facultative anaerobes or obligate (strict) anaerobes, is capsulated (hyaluronic acid capsule) and requires enriched media (blood agar) to grow.

Differentiating typhoid fever from other disease

Strep throat must be differentiated from other diseases that cause sore throat and fever such as epiglottitisperitonsillar abscessretropharyngeal abscess, coxsackie virus, herpangina, influenza, EBV, adenovirus, HIV, measles, rubella, herpes simplex virus, parainfluenza viruses, coronaviruses, rhinoviruses, respiratory syncytial virus gonorrhea, diphtheria, tularemia mycoplasma pneumoniae and other causes such as foreign body (eg, fish bone), chemical exposure, and GERD.

Epidemiology and Demographics

Risk factors

Screening

Natural history and complications

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

X ray

Other diagnostic tests

Treatment

References

  1. Alouf JE, Horaud T (1997). "Streptococcal research at Pasteur Institute from Louis Pasteur's time to date". Adv Exp Med Biol. 418: 7–14. PMID 9331588.
  2. Joseph Ferretti & Werner Kohler (2016). "History of Streptococcal Research". PMID 26866232.
  3. 3.0 3.1 http://www.cdc.gov/groupastrep/diseases-hcp/strep-throat.html Accessed on October 18, 2016
  4. 4.0 4.1 Cunningham MW (2000). "Pathogenesis of group A streptococcal infections". Clin Microbiol Rev. 13 (3): 470–511. PMC 88944. PMID 10885988.
  5. Guilherme L, Faé KC, Oshiro SE, Tanaka AC, Pomerantzeff PM, Kalil J (2007). "T cell response in rheumatic fever: crossreactivity between streptococcal M protein peptides and heart tissue proteins". Curr Protein Pept Sci. 8 (1): 39–44. PMID 17305559.
  6. Fischetti VA (1989). "Streptococcal M protein: molecular design and biological behavior". Clin Microbiol Rev. 2 (3): 285–314. PMC 358122. PMID 2670192.
  7. Stanley J, Desai M, Xerry J, Tanna A, Efstratiou A, George R (1996). "High-resolution genotyping elucidates the epidemiology of group A streptococcus outbreaks". J Infect Dis. 174 (3): 500–6. PMID 8769606.

Template:WH Template:WS